Subhash Kapre
Subhash Kapre is Executive Chairman at Inventprise and Chairman at InventVacc Biologicals Inc. He was Executive Director at Serum Institute of India Limited.
Bill & Melinda Gates Foundation Pledges up to $90M to Fund Inventprise’s 25-Strain Pediatric Pneumococcal Vaccine Trials
Seattle-area biotech Inventprise will use up to $90 million from the Bill & Melinda Gates Foundation to advance a 25-strain pediatric pneumococcal vaccine into phase 1 and 2 human trials, contingent on meeting development and manufacturing milestones.
Organizations
-
Inventprise Executive Chairman 2021–present, CEO 2013–2021 · current
-
InventVacc Biologicals Inc Chairman 2016–present · current
-
Serum Institute of India Limited Executive Director 1969–2011 · past
Education
-
Savitribai Phule Pune University Doctorate in Philosophy, Biochemistry/Microbiology · 1969–1975